Meribank Biotech Co., Ltd
TWO: 4724.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jian-Fang Cai
- Employees
- 142
- Headquarters
- Taipei City, Taiwan
- IPO year
- 2023
- Market cap
- NT$1.3B
- Website
- https://www.meribank.com.tw
Loading 4724…
Loading profile data…Frequently asked questions about 4724
What does Meribank Biotech Co., Ltd (4724.TWO) do?
Meribank Biotech Co., Ltd manufactures, develops, and stores mesenchymal stem cells in Taiwan. The company engages in storage of placental umbilical cord mesenchymal stem cells, cord blood hematopoietic stem cells, and immune cells. It is also involved in cell cryopreservation protocol and postpartum nursing services. Meribank Biotech Co., Ltd w...
Where does 4724.TWO trade?
Meribank Biotech Co., Ltd (4724.TWO) trades on the Taipei Exchange.
What sector is 4724.TWO in?
Meribank Biotech Co., Ltd (4724.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Meribank Biotech Co., Ltd?
Jian-Fang Cai is the chief executive officer of Meribank Biotech Co., Ltd (4724.TWO).
Where is Meribank Biotech Co., Ltd headquartered?
Meribank Biotech Co., Ltd is headquartered in Taiwan.
Does 4724.TWO pay a dividend?
Meribank Biotech Co., Ltd (4724.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4724.TWO go public?
Meribank Biotech Co., Ltd (4724.TWO) completed its initial public offering in 2023.